(Date:11/5/2009)...d two NIH grants of $1 million each to study the u...h records to improve health and HIV prevention out...are funded through the federal stimulus bill, The ...tudy will look at using mobile phone text messages...elp HIV patients, adherence to pill-taking regimen...
(Date:11/5/2009)...eg; Ltd. a global developer, manufacturer and mark...ces for ophthalmic, surgical and aesthetic applica...l study into the efficacy of Selective Retina Ther...dy will take place at the Tel Aviv Medical Center ...enstein MD. , (PRWEB) Nov...
(Date:11/5/2009)...world leader in online-based medical transcription... immediately. , (Vocus) N...ne-based medical transcription, has tapped Randy O..., ,Emdat’s founding partners, who remain act...serve as CEO of the 10-year-old company. Steve Pal...
(Date:11/5/2009)...irstCall/ -- Carriage Services, Inc. (NYSE: CSV )... it has amended and extended its existing senior s...ders, Bank of America and Wells Fargo. Prior to t...s scheduled to mature in April 2010. The amended c...h an accordion provision for an additional $20 mil...
(Date:11/5/2009)...nced next year, company says , , THURSDA...company says it has developed a lower-cost DNA pla...analysis of data from three full human genomes, wa..., Complete Genomics, said the consumables cost for...o just over $8,000. , "We,ve demonstrated that ...
Breaking Medicine News(10 mins):Health News:Federal stimulus funds support studies geared to improving HIV care and prevention 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 2Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 3Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 4Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 5Health News:Lumenis Announces the Initiation of a Clinical Study into the Efficacy of Selective Retina Therapy (SRT) in Diabetic Macular Edema (DME) 6Health News:Randy Olver Named Emdat CEO, Will Lead Next Phase of Growth for Medical Transcription Solutions Provider 2Health News:Carriage Services Amends and Extends Credit Facility 2...goes undiagnosed, , , FRIDAY, May 22 (Heal...2 diabetes often have undiagnosed sleep apnea as w...participants in the study, about 87 percent were f...dy, all obese and all with type 2 diabetes, had pa...
...al Innovations, Inc. (NYSE: IMA ), a global lead... health at home through the merger of rapid diagno...nd of $3.00 per share on its Series B Convertible ....00 divided by (b) 97% of the average of the volum...
...are tough, adults 60 and over may qualify for a li...mic Recovery Act, benefits have risen for the firs... pay the cost of groceries and Medicare premiums, ...orative partnership with community and faith-based...
... In the current edition of Deutsches rzteblatt In...3), Martin Stolle et al. of the German Cen...cence in Hamburg report that the main change has b... problems. , According to the German Federal Com...
...eading healthcare group purchasing and resource ma...ave received the Practice Greenhealth Champion fo...nvironmentally responsible healthcare. Consorta wa...ce on Environmentally Sustainable Health Care. , ...
...azine Launch Public Service Campaign with Designer... GEOFFREY BEENE GIVES BACK(R) and GQ Magazine ...like nine-time Grammy Award winner, Sheryl Crow, a...ether to showcase the need for greater funding and...
Other Medicine News:Health News:Among Obese Diabetics, Sleep Apnea May Be Common 2Health News:A Bright Spot - Financial Help for Seniors 2Health News:Consorta Receives Practice Greenhealth Champion for Change Award for Sixth Consecutive Year 2Health News:Consorta Receives Practice Greenhealth Champion for Change Award for Sixth Consecutive Year 3Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 2Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 3Health News:Photos: The Nation's Leading Scientists and Top Rock Stars Shine a Spotlight on the Promise of Medical Research 4(Date:11/5/2009)...ARKRAY, Inc., the world,s 5th largest manufacturer...ced that it has received 510(k) clearance from the...CARD Vital blood glucose monitoring system. ,, ...l make available for distribution in early Decembe...he existing GLUCOCARD line of products, and will b...
(Date:11/5/2009)...rstCall/ -- Cardiac Science Corporation (Nasda...defibrillator ( AED ) and diagnostic cardiac mon...ran healthcare executive Ronald A. Andrews, Jr., t...me board member Jue-Hsien Chern, Ph.D., who steppe... The total number of directors remains at six. ,...
(Date:11/5/2009)...FirstCall/ -- Genoptix, Inc. (Nasdaq: GXDX ), a s...orted revenues of $50.8 million for the third quar... from changes in accounting estimates resulting pr...ior period revenue. Third quarter revenue increas...rable period in 2008, which included a $2.5 millio...
Breaking Medicine Technology:ARKRAY, Inc. Receives FDA Clearance for New GLUCOCARD(R) Vital(TM) Blood Glucose Monitoring System 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 2Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 3Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 4Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 2Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 3Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 4Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 5Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 6Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 7Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 8Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 9Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 10Genoptix Reports Continued Strong Growth for the Third Quarter and First Nine Months of 2009 11Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 1Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 2Launch of Targeted Agents and Increased Use of Maintenance Therapy Will Drive the Non Small Cell Lung Cancer Drug Market to Nearly Triple to Almost 2 50258 3NeurogesX Added to Russell 3000 Index 12822 1NeurogesX Added to Russell 3000 Index 12822 2NeurogesX Added to Russell 3000 Index 12822 3NeurogesX Added to Russell 3000 Index 12822 4deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 1deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 2deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 3deCODE Discovers a Gene Linked to Risk of Kidney Stones and Osteoporosis 12819 4...egy Requires Public Reporting of HAIs in all ...lif., July 28 Cepheid (Nasdaq:,CPHD) today announ...d,s,GeneXpert(R) System and Xpert(TM) MRSA test fo...itals. Selection of these systems is part of,ongoi...r ,Start Clean,Victorian Infection Control Strateg...
... (Nasdaq: CADX ), a biopharmaceutical company foc...g proprietary product candidates principally,for u...t will release its,second quarter financial result...08., Cadence management will host a conference ca...ts and provide a clinical program update on,Thursd...
Other Medicine Technology:Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy 2Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy 3Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of 'Start Clean' Strategy 4Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Second Quarter 2008 Financial Results and Provide a Clinical Program Update on August 7, 2008 2...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
...ference laboratory and a worldwide leader in innov...fers an extensive test menu of highly complex and ...ology. Owned by the University of Utah, ARUP Labor...ion's university teaching hospitals and children's...
Medicine Products: